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ABSTRACT
Leptospermum flavescens, commonly known as ‘Gelam bukit’ has been used by the Malays as traditional plants in 
Malaysia for antidiabetic treatment. However, at this moment there is no scientific evidence and data available to validate 
such claim. In the present study, the aqueous extract of leaves and stems were studied for its antidiabetic activity. The 
total phenols and flavonoids were determined and correlated with antidiabetic activity. The detection of aqueous leaves 
extract with LCMS/MS showed the presence of flavonoids aromadendrin glucoside, kaempferol rhamnoside, quercetin 
rhamnoside and vindoline. The extract has significantly inhibited glycogen phosphorylase at 85% with IC
50
 = 0.18 
mg/mL. In the alloxan induced diabetic rats showed that extract at 500 mg/kg decreased significantly fasting plasma 
glucose level by 61.9% (p<0.001) on the 20th day as compared to diabetic control. The treatment with Leptospermum 
flavescens at 500 mg/kg showed that it decreased the total cholesterol and triglycerides but restored the HDL level. The 
high antidiabetic activity was correlated with high total phenol at 1.57±0.01 GAE/g and total flavonoids at 1.41±0.01 mg 
QE/g. Thus, the high antidiabetic activity of the aqueous leaves extract attributed due to the presence of aromadendron 
glucoside, kaempferol rhamnoside, quercetin rhamnoside and vindoline in aqueous extract of Leptospermum flavescens. 
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ABSTRAK
Leptospermum flavescens yang lazimnya dikenali sebagai Gelam bukit telah digunakan oleh orang Melayu dalam 
perubatan tradisi untuk rawatan diabetes. Walau bagaimanapun, pada masa ini tiada bukti saintifik dan data tersedia untuk 
mengesahkan dakwaan tersebut. Dalam kajian ini, ekstrak akues daun dan batang dikaji untuk aktiviti antidiabetiknya. 
Jumlah fenol dan flavonoid ditentukan dan berkorelasi dengan aktiviti antidiabetik. Pengesanan ekstrak akues daun dengan 
LCMS/MS menunjukan kehadiran flavonoid glikosida aromadendrin, kaempferol rhamnoside, quercetin rhamnoside dan 
vindoline. Ekstrak mempunyai rencatan signifikan glikogen fosforilase pada 85% dengan IC
50
 = 0.18 mg/mL. Di dalam 
tikus induksi diabetik aloksan menunjukkan ekstrak pada 500 mg/kg signifikan menurunkan paras glukosa plasma puasa 
sebanyak 61.9% (p<0.001) pada hari ke 20 berbanding dengan kumpulan kawalan. Perlakuan dengan Leptospermum 
flavescens pada 500 mg/kg menunjukkan penurunan jumlah kolesterol dan trigliserida tetapi mengekalkan paras HDL. 
Aktiviti antidiabetik yang tinggi berkorelasi dengan jumlah fenol pada 1.57±0.01 GAE/g dan jumlah flavonoid pada 
1.41±0.01 mg QE/g. Maka, aktiviti antidiabetik yang tinggi ekstrak akues daun adalah disebabkan kehadiran glikosida 
aromadendron, kaempferol rhamnoside, quercetin rhamnoside dan vindoline di dalam ekstrak akues Leptospermum 
flavescens. 
Kata kunci: Antidiabetik; fenol; flavonoids; glikogen fosforilase; Leptospermum flavescens
INTRODUCTION
Diabetes is a type of hormonal deficiency disease and almost 
all of diabetes mellitus has been diagnosis as type 2 or non-
insulin dependent diabetes mellitus (Oikonomakus 2002). 
It is caused by the elevation of blood glucose level due to 
either resistance to the biological activity of insulin or by 
abnormal insulin secretion rate (Ross et al. 2004). There are 
several drugs available for the treatment of type 2 diabetes 
such as biguarides (phenformin and metaformin) (Bailey 
1992), thiazolidinediones (TZDs) (Barnett et al. 1977), 
α-glucoside inhibitors (Acarbose) (Asano 2003; Buse et 
al. 1998) and sulfonylureas (glipizide and gliimeperide) 
(Yun et al. 2006). However, these drugs have side effect 
such as weight loss, bloating, metallic taste, abdominal 
pains, hepatic toxicity, weight gain, gastrointestinal 
discomfort and skin rashes. Thus, a new medical treatment 
for diabetes mellitus needs to be developed to control 
blood glucose homeostasis without inherent side effects. 
Glycogen phosphorylase (GP) has been recognized as a 
therapeutic target in searching phytochemical compounds 
of GP inhibitors from medicinal plants for the diabetic 
treatment. In the glycogen metabolism, the liver GP is 
directly responsible for the regulation of hepatic glucose 
output and maintained the blood sugar level. Therefore, the 
inhibition of GP has become accepted treatment for type 2 
diabetes (Moller 2001; Zimmet et al. 2001) to reduce the 
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hepatic glucose production. Secondary plant metabolites 
flavanoids (Prakash et al. 2011), terpenoids (Min-Jia et 
al. 2008) and alkaloids (Jiyin et al. 2009) has been shown 
to possess hypoglycemic effect in vitro and in vivo in 
induced diabetic rats. Furthermore, the uses medicinal 
traditional plants for diabetes treatments are much more 
save, effective, non-toxic with less or no side effect. The 
search for safer and affordable antidiabetic drugs has led 
to the testing of many plants for such activity. 
 Thus, this would give traditional medicines plants to 
play an important role in the control of diabetes mellitus 
(Ahmad et al. 2004; Karunanayake & Tennekoon 1993). 
There are many traditional medicinal plants possesses 
antidiabetic activity has been reported (Day 1998; Mankil 
et al. 2006) such as Tinospora cordifolia (Patel et al. 2009) 
and Jatropoda cucu (Obatomi et al. 1994). Leptospermum 
flavescens belong to the family of Myrtaceae which 
commonly known as ‘Gelam bukit’ by the Malays in 
Malaysia. It has been used in Malay folks to stimulate 
appetite, relieve stomach disorder, menstrual discomfort 
and diabetes (Riley 1994). The present work was 
undertaken to explore the antidiabetic potential of a plant 
Leptospermum flavescens for type 2 diabetic treatments. 
No reports are available on the hypoglycemic activity 
of Leptospermum flavescens in streptozotocin induced 
diabetic rats.
MATERIALS AND METHODS
COLLECTION OF PLANTS SAMPLE
The Leptospermum flavescens was collected from the forest 
at Genting Highland, Pahang, Malaysia. The authentic 
of the plant was identified by plant taxonomist Professor 
Dr. Ong Hean Choi from Institute of Biological Science, 
Faculty of Science, University of Malaya, Kuala Lumpur, 
Malaysia. The leaves, stems and roots were separated and 
air-dried at room temperature for four days. It was then 
grinded into fine powder and kept in sample bottle until 
further used. 
PREPARATION OF AQUEOUS EXTRACTS
The powdered sample of leaves, stems and roots were 
extracted with 100 mL of water. Then the mixture 
was incubated in water bath at 40oC for 2 h. After the 
incubation, the mixture was filtered and the water extract 
was dried in the freeze drier.
SEPARATION AND DETECTION OF CHEMICAL COMPOUNDS
The chemical compounds of the aqueous extract were 
separated using Thin Layer Chromatography (TLC). The 
extract was loaded as a band onto TLC plate size 20 cm × 20 
cm with capillary tube. The TLC separation was developed 
in chromatography tank in 10% methanol/chloroform 
solvent system. The presence of phenols, terpenoids 
and alkaloids were detected with phenol, vanillin H2SO4 
and Dragendorff reagent, respectively. The chemical 
constituents of the extract were determined using LCMS/
MS with known standard references using ionisation mode: 
Positive and Negative; Column: Phenomenex Aqua C18 – 
50 mm × 2.0 mm × 5 uM; Buffer: Water and Acetonitrile 
with 0.1% formic acid and 5 mM ammonium formate. 
1.0 mL of sample extracts were diluted five times with 
methanol and filtered with 0.2 uM nylon filter prior to 
analyses. The mass fragmentations were based on using 
standards samples. 
DETERMINATION OF TOTAL PHENOLS
The total phenolic contents of aqueous extracts were 
determined with the Folin-Ciocalteu reagent using 
method from Spanos and Wrosltad (1990). First, the 
Folin-Ciocalteu reagent was prepared by dissolving Folin-
Ciocalteu reagent in distilled water in 1:10 ratio. 500 μL 
of the the crude extracts was mixed with 5 mL of Folin-
Ciocalteu reagent and 4 mL of 1M of sodium carbonate 
(Na2CO3). The reaction mixture was incubated in water 
bath at 45°C for 15 min. The absorbance of the sample 
was measured at 765 nm with spectrophotometer. The 
total phenol content were determined using standard curve 
prepared from 0, 50, 100, 150, 200, 250 and 500 mg/L of 
gallic acid in methanol solution (50:50/v:v). The results 
were expressed as milligram of gallic acid equivalent per 
gram of dry sample. All of the aqueous extracts were tested 
in duplicate and mean value were calculated. 
DETERMINATION OF TOTAL FLAVONOIDS
The total flavonoid contents of extracts were determined 
using Aluminium chloride colorimetric method with 
slightly modification as described by Liu et al. (2007). 10 
mg/mL of standard concentration samples in methanol 
(1:1) were mixed with 0.3 mL 5% Sodium nitrate and 
incubated for 5 min at 37°C. 0.3 mL 10% aluminium 
chloride was added and incubated for 6 min at 37°C. 
2 mL of Sodium hydroxide and 10 mL distilled water 
was added. Absorbance was measured at 510 nm using 
spectrophotometer. The total flavonoids content was 
determined using a standard curve prepared from 0, 50, 
100, 150, 200, 250 and 500 mg/L of quercetin. The results 
from two replicates were expressed as mg of quarcetin 
equivalent per gram of dry sample.
ENZYMATIC GLYCOGEN PHOSPHORYLASE BIOASSAY
The inhibitory activity of the test compounds against rabbit 
muscle glycogen phosphorylase a (GPa) was monitored 
using microplate reader (BIO-RAD) following the method 
as described by Martin et al. (1998). In brief, GPa activity 
was measured in the direction of glycogen synthesis by the 
release of phosphate from glucose-1-phosphate. Each test 
compound was dissolved in DMSO and diluted at different 
concentrations for IC50 determination. The enzyme was 
added into 100 mL of buffer containing 50 mM Hepes (pH 
7.2), 100 mM KCl, 2.5 mM MgCl2, 0.5 mM glucose-1-
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phosphate, 1 mg/mL glycogen and the test compound in 
96-well microplates (Costar). After the addition of 150 mL 
of 1 M HCl containing 10 mg/mL ammonium molybdate 
and 0.38 mg/mL malachite green, reactions were run at 
22oC for 25 min and then the phosphate absorbance was 
measured at 655 nm. The caffeine was used as a positive 
control standard at 0 – 1 mg/mL. The IC50 values were 
estimated by fitting the inhibition data to a dose-dependent 
curve using a logistic derivative equation.
ANIMALS
The male Sprad Dawley rats aged 2 months and weighing 
120 – 150 g were used for the study. The animals were 
kept in rat cages of six rats per cage and maintained under 
standard conditions at 12 h light and 12 h dark cycle, room 
temperature 30oC, 70–80% relative humidity. They were 
fed with standard rat pellet diet and the animal study was 
carried out under Animal Ethics Committee of Animals 
House, Faculty of Medicine, University of Malaya with 
animal ethic No: ISB/03/03/2010/JM(R). 
ACUTE TOXICITY STUDY
The Sprad Dawley rats in a group of six rats were starved 
overnight. They were fed with the leaves and stems 
aqueous extracts at doses of 200 mg/kg and 500 mg/
kg body weight, respectively. The acute toxicity study 
was carried out according to OECD guidelines - 425. 
The toxic effect on alertness, restlessness, irritability, 
fearless, spontaneous activity, defecation and urination 
was observed continuously for 14 days to see any lethality 
or death.
ORAL GLUCOSE TOLERANCE TEST (OGTT)
The oral glucose tolerance test was carried out according 
to Shirwaikar et al. (2006). The normal rats were fasted 
overnight. The rats were divided into six group consisting 
of six rats in each group and administered with glucose (3 
g/kg), glipizide (2 mg/kg), leaves aqueous extract 200 mg/
kg, 500 mg/kg, stem aqueous extract 200 mg/kg, 500 mg/
kg respectively. The glucose (3 g/kg) was fed 30 min after 
the administration of extracts. Blood was withdrawn from 
the retro orbital sinus under ether inhalation at 0, 30, 60 
and 120 min of glucose administration. The glucose level 
was estimated using glucometer Accu check (USA) with 
glucose-oxidase-peroxidase reactive strips.
INDUCTION OF NON-INSULIN-DEPENDENT DIABETES 
MELLITUS (NIDDM)
The rats weighing 120 – 150 g were induced with 150 
mg/kg body weight of allozan by single intraperitoneal 
injection. Hyperglycermia was confirmed by the evaluated 
glucose level determined at 72 h. Animals with blood 
glucose level more than 12 mmol/L were considered as 
diabetics. Rats found with permanent NIDDM were used 
for the antidiabetic study. Glipizide at 2 mg/kg was used 
as the standard drug. 
ANTIDIABETIC STUDY
The animals were divided into seven groups, each 
consisting of six rats. The extracts were administered for 
20 days. Group I: Normal control rats administered saline 
(0.9%, w/v); Group II: Diabetic control rats administered 
saline (0.9%, w/v); Group III: Diabetic rats administered 
glipizide (2 mg/kg) daily for 20 days; Group IV: Diabetic 
rats administered leaves aqueous extract (200 mg/kg); 
Group V: Diabetic rats administered leaves aqueous extract 
(500 mg/kg); Group VI: Diabetic rats administered stem 
aqueous extract (200 mg/kg); Group VII: Diabetic rats 
administered stem aqueous extract (500 mg/kg). The effects 
of administration of Leptospermum flavescens extracts in 
normal and diabetic rats were observed by measuring 
fasting blood glucose, serum lipid profile and changes 
in body weight. Fasting blood glucose was estimated on 
days 0, 5, 10, 15 and 20 of extracts administration. Serum 
lipid profiles were measured by an auto analyzer (Star 21). 
STATISTICAL ANALYSIS
Data were statistically evaluated using one-way ANOVA, 
followed by Dunnett test using STAT software. The values 
were considered significant when p < 0.05.
RESULTS AND DISCUSSION
The present study reported for the first time the potential 
of Leptospermum flavescent as antidiabetic agent. In this 
study the assessment of the antidiabetic activity of aqueous 
extract from leaves and stem of Leptospermum flavescens 
was investigated. The extract showed a dose-dependent fall 
in FBG (fasting blood glucose) in alloxan induced diabetic 
rats. Alloxan induces diabetes by pancreatic cell damage 
mediated through generation of cytotoxic oxygen free 
radicals. The primary target of these radicals is the DNA 
of pancreatic cells causing DNA fragmentation (Shankar 
et al. 2007). The phytochemical screening of leaves and 
stem extract with thin layer chromatography showed 
the presence of phenolics and terpenoids compounds. 
Table 1 shows that aqueous extract of leaves contained 
highest amount of phenols and flavonoids at 1.57±0.01 
mg and 1.41±0.07 mg per g of dry weight, respectively. 
The leaves aqueous extracts also showed high value of 
LC50 with BSLA (609.14 ug/mL) compared with others 
extracts which indicated that the leaves aqueous extract is 
not toxic and safe to be used as decoction for traditional 
treatment of diabetes. The phenolic compounds have been 
found to be beneficial in controlling diabetes. Several 
workers have shown that the flavonoids, triterpenoids, 
alkaloids and phenolics possessed antidiabetic activity 
(Atta-Ur-Rhemann & Khurshid Zaman 1989; Ivorra et al. 
1989; Kameswara Roa et al. 1997; Oliver-Bener 1986). 
Chakravarthy et al. (1980) have reported that flavonoids 
are able to regenerate the damaged beta cells in the alloxan 
diabetic rats. Similarly, phenolic compounds are found 
to possess antihyperglycemic properties (Manickam 
et al. 1997). Lu et al. (2009) have shown that total 
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flavonoids from leaves of Eriobotrya japonica possessed 
hypoglycemic activity in streptozotocin-induced diabetic 
mice. The LCMS/MS analysis of leaves aqueous extract 
of Leptospermum flavescens showed the presence of 
flavonoid aromadendrin glucoside (Figure 1), kaempferol 
rhamnoside (Figure 2), quercetin rhamnoside (Figure 
3) and vindoline (Figure 4). Chen et al. (2010) have 
determined aromadendrin in Euonymus alatus whereas Wei 
Yun et al. (2011) have reported that aromadendrin isolated 
from Gleditsia sinensis stimulated the glucose uptake 
and improve the insulin resistance in mouse predipocytes 
cell culture. The kaempferol rhamnoside and quercetin 
rhamnoside extracted from Bauhinia megalandra leaves 
have also been shown by Rodriquez et al. (2010) that it 
inhibited glucose intestinal absorption. Similarly, quercetin 
rhamnoside found in Agrimonia eupatoria have been 
reported by Zhang and Cheng (2009) are able to reduce 
blood glucose level in agrimony plants. Several researches 
have reported that Vindoline isolated from Catharanthus 
roseus possess antidiabetic activity (Chattopadhyay et 
al. 1991, 1992; Chattopadhyay 1999; Ghosh & Gupta 
1980). Thus, the presence of these compounds provides 
explanation and evidence for the antidiabetic effect 
of Leptospermum flavescens. Figure 5 shows that the 
aqueous leaves crude extract possessed high inhibition 
of glycogen phosphorylase at 85% inhibition with IC50 at 
0.18 mg/mL. The positive control standard drug caffeine 
at 1 gm/mL gave 95% inhibition and its IC50 was 0.12 mg/
mL. The high inhibition of glycogen phosphorylase of 
aqueous leaves crude extract was attributed to the presence 
of aromadendrin glucoside, kaempferol rhamnoside, 
quercetin rhamnoside and vandoline which has been 
detected by LCMS/MS. Thus, these results supported the 
claim made by traditional practitioners that aqueous 
extract of leaves Leptospermum flavescens are effective 
for diabetic treatment. In the present studies during the 
acute toxicity test, there are no toxic sign such as restless, 
response to touch, fearfulness, urination or death was 
found in male rats at any of the doses given to each rats 
until the end of experimental works. Figure 6 depicts the 
hyperglycemic effect of single oral administration of the 
leaves and stem aqueous extract at 200 mg/kg and 500 
TABLE 1. Total of phenol, flavonoid contents and LC50 BSLA of crude extract of Leptospermum flavescens






























Values indicate mean ± SEM (n = 2)
 FIGURE 1. LCMS/MS profile of Aromadendrin glucoside from leaves aqueous extract of Leptospermum flavescens
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FIGURE 2. LCMS/MS profile of Kaempferol rhamnoside from leaves aqueous extract of Leptospermum flavescens
FIGURE 3. LCMS/MS profile of Quercetin rhamnoside from leaves aqueous extract of Leptospermum flavescens 
mg/kg on OGTT of normal rats, respectively. It showed 
that the glucose administration to normal rats fasted for 
16 h increased plasma glucose level from 5 to 8 at 30 
min and returned to normal glucose level after 2 h. The 
administration of leaves aqueous extract of Leptospermum 
flavescens at the dose of 500 mg/kg bodyweight showed 
significant decrease in plasma glucose level at 60 min than 
the dose of 200 mg/kg body weight as compared to the 
normal group. This indicated that aqueous leaves extract of 
Leptospermum flavescens at 500 kg/mg are able to improve 
glucose tolerance in normal rats. The antihyperglycemic 
activity of the leaves and stem aqueous extract was further 
evaluated in alloxan induced diabetic rats. The results 
in Table 2 shows that fasting blood glucose levels were 
significantly increased in alloxan treated group compared 
with the normal control group (p<0.05; diabetic control 
vs. normal control). This is due to the lack of insulin in 
allozan induced rats by destructing the β cells which leads 
to hyperglycemia. The treatment of diabetic rats with 
Leptospermum flavescens leaves aqueous extract (500 mg/
kg) decreased fasting plasma glucose levels significantly 
(p<0.05) on the 20th day by 61.9% compared to the 0th day. 
Another group treated with leaves aqueous at the dose of 
200 mg/kg body weight did not show significant (p>0.05) 
glucose lowering effect at the end of experiment compared 
to the 0th day, but it decreased glucose level on the 20th day 
by 12.4%. Glucose lowering activity of the extract (200 
mg/kg) was remained statistically significant compared 
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to the diabetic control. From this result it indicates that 
Leptospermum flavescens leaves extract can decrease 
fasting plasma glucose level in a dose-depended manner in 
alloxan induced diabetic rats. The diabetic rats treated with 
standard drug glipizide showed significant reduction in 
fasting plasma glucose levels compared to diabetic control 
group (p<0.05; diabetic control vs. group III) and the same 
effect was observed in Leptospermum flavescens (500 
mg/kg) treated group. It is well known that sulfonylurea 
causes hypoglycemia by increasing insulin secretion from 
pancreas (Del Prato & Pulizzi 2006). The results in Table 
2 shows that Leptospermum flavescens aqueous leaves 
extract in both of the doses 200 mg/kg and 500 mg/kg 
produced hypoglycemia in diabetic rats. This indicated 
that there is impaired in insulin sensitivity through insulin 
receptor of mechanism of enzyme involved in glucose 
 FIGURE 4. LCMS/MS profile of Vindoline from leaves aqueous extract of Leptospermum flavescens
FIGURE 5. Percentage of inhibition of glycogen phosphorylase 
of crude extract from Leptospermum flavescens
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phosphorylation (Benhahhord et al. 2001; ElHilaly & 
Lyoussi 2002). This strongly suggests that the possible 
mechanism by which the antihyperglycemic activity is 
enhanced insulin secretion effect from pancreatic β cells 
due to the presence of aromadendrin glucoside, kaempferol 
rhamnoside, quercetin rhamnoside and vindoline in 
aqueous extract of leaves from Leptospermum flavescens 
which have been detected by LCMS/MS.
 Weight loss is one of the major complications in 
diabetes and it arises due to the impairment in insulin 
action caused by alloxan toxicity (Sancheti et al. 2010). 
Due to this there is a decrease in the body weight of allozan 
induced diabetic animals. As shown in Figure 7, treatment 
with allozan caused a significant (p<0.05) weight loss on 
the 20th day compared with normal control. This may be 
due to the reduction of insulin release from pancreatic β 
cells which leads to hyperglycemia, as a result of increase 
muscle wasting and loss of tissue protein in diabetic rats 
(Salahuddin & Jalalpure 2010). In contrast, rats in normal 
control group continued to gain weight (42%) during the 
4-week of experimental period. Treatment with standard 
drug glipizide increased body weight by 13% in diabetic 
rats. Whereas, diabetic rats treated with Leptospermu 
flavescens leaves aqueous extract (200 mg/kg and 500 mg/
kg) are not significantly reduced the body weight after 20 
days. Thus, it can maintained the lost of the body weight 
compared with their initial level. The levels of serum lipids 
are usually altered in diabetic mellitus (Shirwaikar et al. 
2006). In this study it was observed that in diabetic rats 
the serum triglycerides and total cholesterol levels were 
 Each values are expressed as Mean ± SEM (n = 6)
FIGURE 6. Hyperglycermic effect of aqueous extract of Leptospermum flavescens 
on fasting blood glucose level (FBGL) of normal rats during OGTT
TABLE 2. Effects of aqueous crude extracts of Leptospermum flavescens on fasting 
blood glucose level in diabetics rats
Group
 (n=6)
Treatment Fasting plasma glucose concentration (mmol/L)
0th day 5th day 10th day 15th day 20th day
I Normal Control 4.300 ± 0.292 4.800 ± 0.357 4.700 ± 0.478 4.000 ± 0.510 4.4 ± 0.747
II Diabetic Control 14.100 ± 0.402 15.1 ± 0.727 16.200 ± 0.804 18.100 ± 1.425 20.7 ± 0.597*
III Glipizide (2 mg/kg) 14.900 ± 1.931 13.5 ± 1.924 12.900 ± 1.682 10.600 ± 0.835 9.50 ± 0.257*
IV Diabetic + Leaves aqueous 
extract (200 mg/kg)
15.200 ± 2.342 14.32 ± 3.013 14.12±1.21 13.400 ± 1.940 13.31 ± 0.053*
V Diabetic + Leaves aqueous 
extract (500 mg/kg)
14.500 ± 2.247 10.40 ± 1.206 8.50±1.34 6.71±1.52 5.52±1.07*
VI Diabetic + Stem aqueous 
extract (200 mg/kg)
15.000±1.76 15.22±1.22 15.83±1.71 15.82±1.87 15.45±1.09*
VII Diabetic + Stem aqueous 
extract (500 mg/kg)
15.700±2.01 15.74±2.11 15.44±2.21 15.55±2.54 15.15±3.32*
Each value represents Mean ± SEM (n = 6). *p<0.05 compared with diabetic control
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significantly (p<0.05) elevated and serum HDL cholesterol 
levels were decreased 44.9% in comparison with normal 
control (Table 3). Treatment with Leptospermum flavescens 
leaves extracts at the dose of 500 mg/kg for 20 days to 
the diabetic rats significantly (p<0.05) decreased serum 
triglycerides and total cholesterol levels compared with 
the diabetic control. Treatment with standard drug glipizide 
significantly decreased triglyceride, but there was no 
significant decrease in serum total cholesterol levels 
compared with diabetic control. The serum HDL levels in 
both of the Leptospermum flavescens and glipizide treated 
groups were restored to the control level. This is due to 
the effect of aqueous extract increased the utilization 
of glucose and depressing the metabolism of fat. These 
data are consistent with previous report which stated 
that administration of high-fat diet with powdered fruit 
of Sophora species significantly decreased body weight 
in diabetic mice, exhibited lowering triglyceride and 
TABLE 3. Effect of aqueous extracts of Leptospermum flavescens on serum lipid profile in diabetic rats
Group 
(n=6)
Treatment  Serum lipid profile (mmol/L)
TG TC HDL LDL
I Normal control 0.619 ± 0.051 1.647 ± 0.053 0.631± 0.037 0.736 ± 0.064
II Diabetic control 1.838 ± 0.100* 3.200 ± 0.068* 0.348 ± 0.031* 1.509 ± 0.072*
III Glipizide (2 mg/kg) 0.949 ± 0.108* 1.686 ± 0.073* 0.697 ± 0.107* 0.631 ± 0.111*
IV Diabetic + Leaves 
aqueous extract 
(200 mg/kg)
1.523 ± 0.047* 3.075 ± 0.083 0.788 ± 0.065* 0.685 ± 0.005*
V Diabetic + Leaves 
aqueous extract 
(500 mgg/kg)
0.859 ± 0.076* 1.456 ± 0.058* 0.702 ± 0.066* 0.803 ± 0.047*
VI Diabetic + Stem 
aqueous extract 
(200 mg/kg)
0.800 ± 0.000* 1.150 ± 0.018* 0.670 ± 0.080*  0.623± 0.092*
VII Diabetic + Stem 
aqueous extract 
(500 mg/kg)
0.710 ± 0.073* 1.750 ± 0.018* 0.645 ± 0.064* 0.750 ± 0.011*
Each value represents Mean ± SEM (n = 6). *p<0.05 compared with diabetic control
Each values are expressed as Mean ± SEM (n = 6)
 FIGURE 7. The effect of aqueous extract of Leptospermum flavescens on body weight of diabetic rats 
  1303
cholesterol effects while at the same time increasing HDL 
cholesterol in hyperlipidemic and cholesterol-fed rats 
(Hyun et al. 2008; Park et al. 2009). 
CONCLUSION
The leaves aqueous extract of Leptospermum flavescens has 
been shown to contain aromadendrin glucoside, kaempferol 
rhamnoside, quercetin rhamnoside and vandoline with 
LCMS/MS. It showed no toxic effect of Leptospermum 
flavescens on male rats. Furthermore, the leaves aqueous 
extract showed high glycogen phosphorylase activity and 
reduced glucose significantly at concentration 500 mg/
kg in diabetic rats. In addition, the leaves aqueous extract 
decreased the serum trigliserides and total cholesterol 
level in diabetic rats while the level of HDL are maintained 
compared with the control rats. Thus, the results obtained 
from this study provide novel evidence in supporting 
the traditional uses of Leptospermum flavescens as an 
antidiabetic remedy and its complications.
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